Get startedLog in
    Picture of Biocon logo

    BIOCON — Biocon Income Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareBalancedLarge CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Biocon, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    R2020
    March 31st
    R2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:Interim ReportInterim ReportARSARSARS
    Standards:——
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue63,00571,43181,840111,742147,557
    Cost of Revenue
    Gross Profit39,38144,91349,78568,23892,712
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses51,80860,25870,79596,225128,786
    Operating Profit11,19711,17311,04515,51718,771
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes12,14910,6779,8318,97115,252
    Provision for Income Taxes
    Net Income After Taxes8,9988,4627,7166,43012,978
    Minority Interest
    Net Income Before Extraordinary Items
    Extraordinary Items
    Net Income7,4827,4056,4844,62710,225
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income7,4827,4056,4844,62710,225
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS6.135.15.974.357.89
    Dividends per Share